Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)

Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
Sung Uk Lee
1Center for Proton Therapy and Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinsil Seong
2Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tae Hyun Kim
1Center for Proton Therapy and Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tae Hyun Kim
  • For correspondence: [email protected] [email protected]
Jung Ho Im
2Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Korea
3Department of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13497, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Woo Chul Kim
4Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine, Incheon 22332, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyubo Kim
5Department of Radiation Oncology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul 07985, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hae Jin Park
6Department of Radiation Oncology, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul 04763, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tae Gyu Kim
7Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youngkyong Kim
8Department of Radiation Oncology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul 02447, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bae Kwon Jeong
9Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Hee Kim
10Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu 41931, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byoung Hyuck Kim
11Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taek-Keun Nam
12Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun 58128, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Sharma A,
    2. Sharma KL,
    3. Gupta A,
    4. Yadav A,
    5. Kumar A.
    Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017; 23: 3978–98.
    OpenUrlPubMed
  2. 2.↵
    1. Jarnagin WR,
    2. Ruo L,
    3. Little SA,
    4. Klimstra D,
    5. D’Angelica M,
    6. DeMatteo RP, et al.
    Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003; 98: 1689–700.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Wang J,
    2. Narang AK,
    3. Sugar EA,
    4. Luber B,
    5. Rosati LM,
    6. Hsu CC, et al.
    Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: a multi-institutional experience. Ann Surg Oncol. 2015; 22: S1100–6.
    OpenUrl
  4. 4.
    1. Czito BG,
    2. Hurwitz HI,
    3. Clough RW,
    4. Tyler DS,
    5. Morse MA,
    6. Clary BM, et al.
    Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 2005; 62: 1030–4.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Kresl JJ,
    2. Schild SE,
    3. Henning GT,
    4. Gunderson LL,
    5. Donohue J,
    6. Pitot H, et al.
    Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys. 2002; 52: 167–75.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Takada T,
    2. Amano H,
    3. Yasuda H,
    4. Nimura Y,
    5. Matsushiro T,
    6. Kato H, et al.
    Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002; 95: 1685–95.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Park JS,
    2. Yoon DS,
    3. Kim KS,
    4. Choi JS,
    5. Lee WJ,
    6. Chi HS, et al.
    Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma. J Gastrointest Surg. 2007; 11: 631–7.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Kim WS,
    2. Choi DW,
    3. You DD,
    4. Ho CY,
    5. Heo JS,
    6. Choi SH.
    Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010; 14: 679–87.
    OpenUrlPubMed
  9. 9.↵
    1. Cho SY,
    2. Kim SH,
    3. Park SJ,
    4. Han SS,
    5. Kim YK,
    6. Lee KW, et al.
    Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010; 102: 87–93.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.
    1. Duffy A,
    2. Capanu M,
    3. Abou-Alfa GK,
    4. Huitzil D,
    5. Jarnagin W,
    6. Fong Y, et al.
    Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008; 98: 485–9.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.
    1. Hyder O,
    2. Dodson RM,
    3. Sachs T,
    4. Weiss M,
    5. Mayo SC,
    6. Choti MA, et al.
    Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched surveillance, epidemiology, and end results analysis. Surgery. 2014; 155: 85–93.
    OpenUrl
  12. 12.↵
    1. Kim TH,
    2. Woo SM,
    3. Lee WJ,
    4. Oh ES,
    5. Youn SH,
    6. Moon SH, et al.
    Benefit of adjuvant chemoradiotherapy in resected gallbladder carcinoma. Sci Rep. 2019; 9: 11770.
  13. 13.↵
    1. Lee HC,
    2. Lee JH,
    3. Lee SW,
    4. Lee JH,
    5. Yu M,
    6. Jang HS, et al.
    Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer. Radiat Oncol J. 2019; 37: 279–85.
    OpenUrl
  14. 14.↵
    1. Ben-Josef E,
    2. Guthrie KA,
    3. El-Khoueiry AB,
    4. Corless CL,
    5. Zalupski MM,
    6. Lowy AM, et al.
    SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015; 33: 2617–22.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Kim Y,
    2. Amini N,
    3. Wilson A,
    4. Margonis GA,
    5. Ethun CG,
    6. Poultsides G, et al.
    Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis. Ann Surg Oncol. 2016; 23: 2998–3008.
    OpenUrlCrossRefPubMed
  16. 16.
    1. Im JH,
    2. Lee WJ,
    3. Kang CM,
    4. Hwang HK,
    5. Seong J.
    Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer. HPB (Oxford). 2020; 22: 1168–73.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Kim TG.
    Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy. Radiat Oncol J. 2017; 35: 359–67.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Wang SJ,
    2. Lemieux A,
    3. Kalpathy-Cramer J,
    4. Ord CB,
    5. Walker GV,
    6. Fuller CD, et al.
    Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011; 29: 4627–32.
    OpenUrlAbstract/FREE Full Text
  19. 19.
    1. Manterola C,
    2. Duque G,
    3. Grande L,
    4. de Aretxabala X,
    5. Conejeros R,
    6. Otzen T, et al.
    A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer. HPB (Oxford). 2019; 21: 1427–35.
    OpenUrl
  20. 20.↵
    1. Mantripragada KC,
    2. Hamid F,
    3. Shafqat H,
    4. Olszewski AJ.
    Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base. J Natl Cancer Inst. 2017; 109: djw202.
  21. 21.↵
    1. Mitin T,
    2. Enestvedt CK,
    3. Jemal A,
    4. Sineshaw HM.
    Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival. J Natl Cancer Inst. 2017; 109: djw324.
  22. 22.↵
    1. Kim BH,
    2. Kwon J,
    3. Chie EK,
    4. Kim K,
    5. Kim YH,
    6. Seo DW, et al.
    Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018; 25: 255–64.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Jensen EH,
    2. Abraham A,
    3. Jarosek S,
    4. Habermann EB,
    5. Al-Refaie WB,
    6. Vickers SA, et al.
    Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery. 2009; 146: 706–13.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Horgan AM,
    2. Amir E,
    3. Walter T,
    4. Knox JJ.
    Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30: 1934–40.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Primrose JN,
    2. Fox RP,
    3. Palmer DH,
    4. Malik HZ,
    5. Prasad R,
    6. Mirza D, et al.
    Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019; 20: 663–73.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 19 (6)
Cancer Biology & Medicine
Vol. 19, Issue 6
15 Jun 2022
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim, Taek-Keun Nam
Cancer Biology & Medicine Jun 2022, 19 (6) 931-944; DOI: 10.20892/j.issn.2095-3941.2020.0667

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim, Taek-Keun Nam
Cancer Biology & Medicine Jun 2022, 19 (6) 931-944; DOI: 10.20892/j.issn.2095-3941.2020.0667
Digg logo Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Assessments and statistical analysis
    • Results
    • Discussion
    • Conclusions
    • Grant support
    • Conflict of interest statement
    • Author contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Acetylated-PPARγ expression is regulated by different P53 genotypes associated with the adipogenic differentiation of polyploid giant cancer cells with daughter cells
  • Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study
  • MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
Show more Original Article

Similar Articles

Keywords

  • Gallbladder cancer
  • adjuvant treatment
  • chemoradiotherapy
  • locoregional recurrence-free survival
  • overall survival

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire